In Q4 2024, HCA Healthcare demonstrated growth in revenue and operating metrics but faced profitability challenges due to hurricane-related disruptions. Strategic initiatives supported admissions growth, though outpatient procedures declined.
📊 Income Statement Highlights (vs Q4 2023):
▫️Net Income: $1.44B vs $1.61B (-10.51%)
▫️Total Revenue: $18.29B vs $17.30B (+5.68%)
▫️Adjusted EPS: $6.22 vs $5.90 (+5.42%)
▫️Gross Margin: 11.67% vs 12.33%
▫️Operating Income: $2.13B vs $2.18B (-2.29%)
▫️Adjusted EBITDA: $3.71B vs $3.62B (+2.55%)
▫️Same Facility Revenue/Equivalent Admission: $18,185 (+2.9%)
Other Metrics:
▫️Same Facility Admissions: +3.0%
▫️Emergency Room Visits: +2.4%
▫️Inpatient Surgeries: +2.8%; Outpatient Surgeries: -1.3%
💼 Balance Sheet Highlights (vs Dec 31, 2023):
▫️Total Assets: $59.51B (+0.94%)
▫️Cash and Cash Equivalents: $1.93B (+106.68%)
▫️Total Liabilities: $43.03B (+0.23%)
▫️Equity: $0.56B
Other Key Figures:
▫️Debt: $43.03B
▫️Share Repurchases: $1.70B in Q4; $764M remains under authorization.
▫️Capital Expenditures (excluding acquisitions): $1.29B
🔮 Future Outlook:
▫️2025 Revenue Guidance: $72.80B to $75.80B
▫️Net Income: $5.85B to $6.29B
▫️Adjusted EBITDA: $14.30B to $15.10B
▫️EPS: $24.05 to $25.85
▫️Capital Expenditures: $5.0B to $5.2B
🌟 Special Considerations:
▫️Hurricanes Helene and Milton impacted operations, contributing to a $200M revenue loss. All facilities have resumed normal operations.
▫️HCA’s board authorized an additional $10B share repurchase program.
▫️Q4 2024 dividends declared: $0.72/share.